Medvi: 800 Fake Doctors and Criticism of AI in Telehealth

Medvi: Rapid Growth Driven by AI

Medvi, a telehealth startup, was founded in 2024 by Matthew Gallagher. The company focuses on weight loss treatments using GLP-1 and aims to reach $1.8 billion in annual sales by 2026. This success largely relies on advanced automation powered by artificial intelligence, allowing Medvi to operate with a very small number of employees.

Controversial Business Practices

Despite this impressive rise, Medvi is under fire for some of its practices. Flaws in the automated medical journey have been revealed, including the acceptance of treatment requests with weight goals deemed unrealistic. Additionally, advertisements mentioning "800 doctors" have surfaced, but it appears these figures come from external affiliates, raising questions about the truthfulness of the advertising messages.

Automation and Risk Control

Automation is at the heart of Medvi's model, covering areas such as marketing and customer support. However, users have reported that unrealistic weight goals were approved, casting doubt on the effectiveness of the controls in place. This situation has drawn the attention of authorities, including the FTC and the FDA, who are concerned about potentially misleading advertising practices.

Misleading Advertisements and Regulatory Framework

The figure of "800 doctors" has been used in Facebook advertisements, but it seems these ads are managed by paid affiliates, rather than directly by Medvi. This situation raises concerns about the company's control over its advertising practices. Medvi operates in an increasingly scrutinized legal environment by U.S. authorities, who are interested in misleading advertisements in the telehealth sector. Although Medvi is not yet facing lawsuits, its business model based on the online sale of GLP-1 treatments and the automation of marketing processes is under close examination.